Similar articles

• Systemic effects of topically applied methylprednisolone aceponate in healthy volunteers.

  Kecskés A, Jahn P, Matthes H, Kuhlmann RK, Lange L. Kecskés A, et al. J Am Acad Dermatol. 1993 May;28(5 Pt 1):789-92. doi: 10.1016/s0190-9622(09)80276-4. J Am Acad Dermatol. 1993. PMID: 8496431 Clinical Trial. No abstract available.
• Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.

  Kerscher MJ, Korting HC. Kerscher MJ, et al. Acta Derm Venereol. 1992;72(3):214-6. Acta Derm Venereol. 1992. PMID: 1357864 Clinical Trial.
• Side effects of topical glucocorticoids.

  Mills CM, Marks R. Mills CM, et al. Curr Probl Dermatol. 1993;21:122-31. doi: 10.1159/000422371. Curr Probl Dermatol. 1993. PMID: 8299365 Review. No abstract available.
• Topical glucocorticoids and thinning of normal skin as to be assessed by ultrasound.

  Korting HC. Korting HC. Curr Probl Dermatol. 1993;21:114-21. doi: 10.1159/000422370. Curr Probl Dermatol. 1993. PMID: 8299364 No abstract available.
• Steroids in dermatology.

  Miller JA, Levene GM. Miller JA, et al. Br J Hosp Med. 1982 Oct;28(4):331-2, 337-8. Br J Hosp Med. 1982. PMID: 6291678 Review. No abstract available.